Acquisitions (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Business Combination [Line Items] |
|
| Schedule of Change in Carrying Value of Goodwill |
The carrying amount of goodwill by reporting segment as of March 31, 2026 and December 31, 2025 is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, 2026 |
|
|
December 31,
2025 |
|
Specialist isotopes and related services |
|
$ |
6,394 |
|
|
$ |
5,177 |
|
Total goodwill |
|
$ |
6,394 |
|
|
$ |
5,177 |
|
The changes to the carrying value of goodwill, which is included in the isotopes and related services segment, is as follows:
|
|
|
|
|
Description |
|
Amount |
|
Balance as of December 31, 2025 |
|
$ |
5,177 |
|
Acquisition of Numed |
|
|
1,331 |
|
Translation adjustment |
|
|
(114 |
) |
Balance as of March 31, 2026 |
|
$ |
6,394 |
|
|
| Summary of Changes to Carrying Value of Intangible Assets |
The changes to the carrying value of intangible assets, which is included in the construction services and specialist isotopes and related services segments, is as follows (in thousands):
|
|
|
|
|
Description |
|
Amount |
|
Balance as of December 31, 2024 |
|
$ |
— |
|
Trademarks from ECNP acquisition |
|
|
430 |
|
Amortization |
|
|
(21 |
) |
Balance as of December 31, 2025 |
|
$ |
409 |
|
Trademarks from Numed acquisition |
|
|
300 |
|
Amortization |
|
|
(34 |
) |
Balance as of March 31, 2026 |
|
$ |
675 |
|
|
| Summary of Estimated Future Amortization Expense Related to Intangible Assets Held |
The following table outlines the estimated future amortization expense related to intangible assets held as of December 31, 2025 (in thousands):
|
|
|
|
|
|
|
Amortization Expense |
|
Year Ended December 31, |
|
|
|
2026 |
|
$ |
121 |
|
2027 |
|
|
161 |
|
2028 |
|
|
161 |
|
2029 |
|
|
161 |
|
2030 |
|
|
71 |
|
Thereafter |
|
|
— |
|
Total |
|
$ |
675 |
|
|
| East Coast Nuclear Pharmacy, LLC |
|
| Business Combination [Line Items] |
|
| Summary of Preliminary Allocation of Purchase Consideration to Fair Value of Assets Acquired and Liabilities Assumed |
The following table summarizes the allocation of the purchase consideration to the fair value of the assets acquired and liabilities assumed (in thousands):
|
|
|
|
|
Fair value of business combination |
|
|
|
Cash consideration |
|
$ |
2,000 |
|
Notes payable to Sellers |
|
|
500 |
|
Identifiable assets acquired and liabilities assumed |
|
|
|
Cash and cash equivalents |
|
|
40 |
|
Accounts receivable |
|
|
550 |
|
Inventory |
|
|
92 |
|
Prepaid expenses and other current assets |
|
|
6 |
|
Identifiable intangible assets |
|
|
430 |
|
Accounts payable |
|
|
(113 |
) |
Other current liabilities |
|
|
(79 |
) |
Total identifiable assets acquired and liabilities assumed |
|
|
926 |
|
Goodwill |
|
|
1,574 |
|
Total purchase consideration |
|
$ |
2,500 |
|
|
| Numed Diagnostics, LLC |
|
| Business Combination [Line Items] |
|
| Summary of Preliminary Allocation of Purchase Consideration to Fair Value of Assets Acquired and Liabilities Assumed |
The following table summarizes the preliminary allocation of the purchase consideration to the fair value of the assets acquired and liabilities assumed (in thousands):
|
|
|
|
|
Fair value of business combination |
|
|
|
Cash consideration |
|
$ |
813 |
|
Contingent Consideration |
|
|
358 |
|
Identifiable assets acquired and liabilities assumed |
|
|
|
Cash and cash equivalents |
|
|
80 |
|
Accounts receivable |
|
|
170 |
|
Inventory |
|
|
66 |
|
Property and equipment, net |
|
|
107 |
|
Other noncurrent assets |
|
|
4 |
|
Identifiable intangible assets |
|
|
300 |
|
Accounts payable |
|
|
(208 |
) |
Deferred tax liabilities |
|
|
(80 |
) |
Other current liabilities |
|
|
(2 |
) |
Total identifiable assets acquired and liabilities assumed |
|
|
437 |
|
Goodwill |
|
|
1,331 |
|
Noncontrolling interest |
|
|
(597 |
) |
Total purchase consideration |
|
$ |
1,171 |
|
|
| Renergen |
|
| Business Combination [Line Items] |
|
| Summary of Preliminary Allocation of Purchase Consideration to Fair Value of Assets Acquired and Liabilities Assumed |
The following table summarizes the preliminary allocation of the purchase consideration to the fair value of the assets acquired and liabilities assumed (in thousands):
|
|
|
|
|
Fair value of business combination |
|
|
|
Equity consideration |
|
$ |
92,897 |
|
Cash consideration |
|
|
5 |
|
Note receivable |
|
|
32,119 |
|
Identifiable assets acquired and liabilities assumed |
|
|
|
Cash and cash equivalents |
|
|
1,218 |
|
Restricted cash - short term |
|
|
2,789 |
|
Accounts receivable |
|
|
3,205 |
|
Lessor Receivable |
|
|
2,434 |
|
Restricted cash - long term |
|
|
1,650 |
|
Inventory |
|
|
40 |
|
Property and equipment, net |
|
|
61,573 |
|
Natural gas properties |
|
|
133,412 |
|
Operating lease right-of-use asset, net |
|
|
811 |
|
Accounts payable |
|
|
(4,820 |
) |
Finance lease liabilities – current |
|
|
(55 |
) |
Operating lease liabilities – current |
|
|
(195 |
) |
Borrowings |
|
|
(58,664 |
) |
Deferred revenue |
|
|
(819 |
) |
Finance lease liabilities – noncurrent |
|
|
(204 |
) |
Operating lease liabilities – noncurrent |
|
|
(616 |
) |
Other liabilities - long term |
|
|
(3,287 |
) |
Deferred tax liabilities |
|
|
(6,175 |
) |
Total identifiable assets acquired and liabilities assumed |
|
|
132,297 |
|
Noncontrolling interest |
|
|
(7,276 |
) |
Total purchase consideration |
|
$ |
125,021 |
|
|